| Testosterone therapy in premenopausal women. | |
| | |
MedLine Citation:
|
PMID: 16633984 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Testosterone therapy for postmenopausal women and women with surgical menopause, albeit controversial, is becoming more widespread. However, only limited data are available to support its use in premenopausal women. Androgens have important biological roles in young women, influencing bone and muscle mass, mood and well-being, and libido. Pathophysiological states affecting ovarian and adrenal function or both may result in androgen deficiency in premenopausal women. Young women with hypothalamic amenorrhea, premature ovarian failure, oophorectomy, premenstrual syndrome, acquired immunodeficiency wasting syndrome, adrenal insufficiency, and hypopituitarism may have testosterone deficiency. Young women with loss of libido may also have testosterone deficiency. Medications that may lead to testosterone insufficiency include oral estrogen, oral contraceptives, and corticosteroids. Testosterone deficiency in young women may be underdiagnosed because the symptoms generally are nonspecific and the measurement of total and free testosterone is inaccurate with commonly used techniques. Only a few studies investigating the effects of testosterone therapy have been performed thus far in premenopausal women. Long-term trials evaluating safety and effectiveness of testosterone therapy in premenopausal women are lacking. Common adverse effects include hirsutism and acne, which reverse with discontinuation of treatment. The availability of testosterone regimens specifically designed for women is expected to help maintain testosterone levels within the normal range and clarify whether the apparent beneficial effects of testosterone therapy are physiological or pharmacological. |
| | |
Authors:
|
Sophia N Kalantaridou; Karim A Calis |
Related Documents
:
|
22252124 - Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery ... 16325024 - Hormone therapies in women aged 40 and older: prevalence and correlates of use. 12432704 - Treating osteoporosis without hormones. 15665654 - The impact of the women's health initiative on discontinuation of postmenopausal hormon... 10362034 - Fresh fruit intake and asthma symptoms in young british adults: confounding or effect m... 2152844 - The rate of bone mineral loss in normal men and the effects of calcium and cholecalcife... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in reproductive medicine Volume: 24 ISSN: 1526-8004 ISO Abbreviation: Semin. Reprod. Med. Publication Date: 2006 Apr |
Date Detail:
|
Created Date: 2006-04-24 Completed Date: 2006-06-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100909394 Medline TA: Semin Reprod Med Country: United States |
Other Details:
|
Languages: eng Pagination: 106-14 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology; University of Ioannina School of Medicine, Panepistimiou Avenue, 45110 Ioannina, Greece. sophia_kalantaridou@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Androgens / deficiency, physiology Bone and Bones / physiology Breast Neoplasms Cardiovascular Diseases Endometrial Neoplasms Female Humans Libido Middle Aged Muscle, Skeletal / physiology Premenopause* Risk Factors Sexual Behavior / physiology Testosterone / adverse effects, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Androgens; 58-22-0/Testosterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dehydroepiandrosterone therapy as female androgen replacement.
Next Document: Testosterone therapy for postmenopausal women: efficacy and safety.